Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Chaoju Eye Care Holdings's Median PS Value or its related term are showing as below:
HKSE:02219's Price-to-Median-PS-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.72 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Chaoju Eye Care Holdings (HKSE:02219) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Chaoju Eye Care Holdings's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
2.47
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chaoju Eye Care Holdings Median PS Value Related Terms
Chaoju Eye Care Holdings Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02219 vs HCA, THC, EHC: Median PS Value Comparison
For the Medical Care Facilities subindustry, Chaoju Eye Care Holdings's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chaoju Eye Care Holdings Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Chaoju Eye Care Holdings's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Chaoju Eye Care Holdings's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Chaoju Eye Care Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was HK$2.225.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chaoju Eye Care Holdings (HKSE:02219) has a Median PS Value of HK$0.00 as of Sep. 01, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Chaoju Eye Care Holdings and its competitors. According to the industry distribution chart, Chaoju Eye Care Holdings ranks #999999 out of 267 companies in the Healthcare Providers & Services industry.
Is Chaoju Eye Care Holdings' Median PS Value too high?
Chaoju Eye Care Holdings' current Median PS Value is HK$0.00. Based on the distribution chart, Chaoju Eye Care Holdings ranks #999999 out of 267 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Chaoju Eye Care Holdings has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chaoju Eye Care Holdings' Median PS Value compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Chaoju Eye Care Holdings ranks #999999 out of 267 companies for Median PS Value. This places Chaoju Eye Care Holdings in the lower half of its industry. The industry median Median PS Value is 0.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.72, based on 267 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Chaoju Eye Care Holdings and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chaoju Eye Care Holdings's current Median PS Value is HK$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chaoju Eye Care Holdings stock overvalued right now?
Based on GuruFocus' analysis, Chaoju Eye Care Holdings (HKSE:02219) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$3.47, compared to a current price of HK$2.47 — trading 28.8% below its estimated fair value. The current Median PS Value is HK$0.00. Chaoju Eye Care Holdings' overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Chaoju Eye Care Holdings (HKSE:02219), the current Median PS Value is HK$0.00 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chaoju Eye Care Holdings (HKSE:02219) Overvalued in 2026?
Based on GuruFocus' analysis, Chaoju Eye Care Holdings stock appears to be undervalued.
The current stock price of HK$2.47 is trading 28.8% below its estimated GF Value™ of HK$3.47.
GuruFocus considers Chaoju Eye Care Holdings to be Modestly Undervalued.
Key valuation signals for HKSE:02219:
Median PS Value: HK$0.00
GF Value™: HK$3.47 vs. price of HK$2.47 (28.8% below fair value)
No single metric tells the full story. See the HKSE:02219 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chaoju Eye Care Holdings Ltd is an ophthalmic medical service group in North China engaged in the provision of in-patient services, out-patient services, and sales of optical products. The company generates revenue from consumer ophthalmic services and basic ophthalmic services. The consumer ophthalmic services include treatments and prevention of various types of ophthalmic disorders, including refractive correction, myopia control, and the provision of optical products and services. The basic ophthalmic services include treatments of a wide range of common eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases, and pediatric eye diseases.
92GF Score
Get the complete analysis for HKSE:02219
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02219 has been successfully added to your 
